Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$398M |
| 2 |
Apple
AAPL
|
+$326M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$286M |
| 4 |
UnitedHealth
UNH
|
+$267M |
| 5 |
Veralto
VLTO
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$730M |
| 2 |
Meta Platforms (Facebook)
META
|
+$674M |
| 3 |
Costco
COST
|
+$635M |
| 4 |
Amazon
AMZN
|
+$528M |
| 5 |
Expedia Group
EXPE
|
+$491M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29% |
| 2 | Healthcare | 13.85% |
| 3 | Consumer Discretionary | 11.46% |
| 4 | Financials | 11.04% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Xencor
XNCR
$1.44B
| $162K | ﹤0.01% |
7,852
+413
| +6% | +$7.86K |
|
|
ONT
1577
Onterris Inc
ONT
$710M
| $161K | ﹤0.01% |
5,665
-656
| -10% | -$18.8K |
|
1578
Marqeta
MQ
$1.8B
| $161K | ﹤0.01% |
+6,333
| New | +$152K |
|
1579
Ligand Pharmaceuticals
LGND
$6.02B
| $159K | ﹤0.01% |
2,165
+141
| +7% | +$8.32K |
|
1580
United Natural Foods
UNFI
$3.01B
| $159K | ﹤0.01% |
10,471
+1,041
| +11% | +$15.8K |
|
|
AD
1581
Array Digital Infrastructure
AD
$3.02B
| $158K | ﹤0.01% |
3,800
-238
| -6% | -$10.1K |
|
1582
National Beverage
FIZZ
$2.87B
| $157K | ﹤0.01% |
3,143
+176
| +6% | +$8.42K |
|
|
VBTX
1583
DELISTED
Veritex Holdings
VBTX
| $157K | ﹤0.01% |
7,017
+468
| +7% | +$9.21K |
|
1584
TORM
TRMD
$3.1B
| $157K | ﹤0.01% |
4,750
| – | – |
|
1585
Pegasystems
PEGA
$4.41B
| $156K | ﹤0.01% |
6,714
| – | – |
|
1586
Allegiant Air
ALGT
$2.64B
| $154K | ﹤0.01% |
1,959
| – | – |
|
|
CCC
1587
CCC Intelligent Solutions
CCC
$3.42B
| $152K | ﹤0.01% |
14,026
+2,928
| +26% | +$34.2K |
|
1588
Leslie's
LESL
$11.6M
| $152K | ﹤0.01% |
1,163
| – | – |
|
1589
Alector
ALEC
$164M
| $151K | ﹤0.01% |
18,638
-24,085
| -56% | -$143K |
|
1590
iShares US Home Construction ETF
ITB
$2.41B
| $150K | ﹤0.01% |
+1,500
| New | +$127K |
|
1591
Corcept Therapeutics
CORT
$10.2B
| $150K | ﹤0.01% |
5,981
| – | – |
|
1592
DNOW Inc
DNOW
$2.63B
| $149K | ﹤0.01% |
14,838
+1,585
| +12% | +$17.4K |
|
1593
Encore Capital Group
ECPG
$1.93B
| $149K | ﹤0.01% |
2,973
| – | – |
|
1594
Travel + Leisure Co
TNL
$4.54B
| $148K | ﹤0.01% |
3,756
+1,519
| +68% | +$55.1K |
|
1595
NCR Voyix
VYX
$1.06B
| $148K | ﹤0.01% |
9,066
-5,712
| -39% | -$91.1K |
|
|
TGI
1596
DELISTED
Triumph Group
TGI
| $148K | ﹤0.01% |
9,699
| – | – |
|
|
MDRX
1597
DELISTED
Veradigm Inc. Common Stock
MDRX
| $147K | ﹤0.01% |
13,685
| – | – |
|
1598
Wabash National
WNC
$543M
| $147K | ﹤0.01% |
6,012
| – | – |
|
1599
Copa Holdings
CPA
$5.56B
| $146K | ﹤0.01% |
1,426
-18,513
| -93% | -$1.69M |
|
1600
Matthews International
MATW
$864M
| $145K | ﹤0.01% |
4,171
+203
| +5% | +$7.44K |
|
Similar funds
Amundi's Q4 2023 Portfolio in Review
As of Q4 2023, Amundi held 2,118 positions worth $222B, up 9.2% from $203B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Amundi's Q4 2023 filing shows 107 new, 857 increased, 762 reduced and 120 closed positions. Its largest new stake was Veralto: 3,549,374 shares worth $276M. The largest sale was Wells Fargo 7.5% Non Cumv Perp Conv, an estimated $730M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amundi's largest Q4 2023 buy was Veralto: 3,549,374 shares worth $276M.
- Amundi added most to Johnson & Johnson in Q4 2023, an estimated $398M increase.
- Amundi's biggest Q4 2023 reduction was Wells Fargo 7.5% Non Cumv Perp Conv, cutting an estimated $730M.
- Amundi fully exited Activision Blizzard in Q4 2023, selling an estimated $284M.
- Amundi's ten largest holdings make up 23% of its $222B portfolio in Q4 2023.
- Amundi opened 107 new positions and closed 120 in Q4 2023.
- Amundi's portfolio value rose 9.2% quarter-over-quarter to $222B.
Based on Amundi's 13F filing for Q4 2023, filed 14 Feb 2024.